Ottawa, September 15, 2022 — The effects of drug-impaired driving (DID) are underreported and therefore not well understood in Canada.
Presents the Canadian Centre on Substance Use and Addiction’s submission to the Office of Legislative and Regulatory Affairs, Controlled Substances and Overdose Response Directorate at Health Canada, as part of consultations.
Summarizes the importance of sex-, gender- and diversity-based analysis (SGBA+) in the substance use and addiction field and outlines how to integrate it into research, programs and policies.
Outlines evidence suggesting the Standardized Field Sobriety Test can be supplemented with other tests and observations to help law enforcement officers detect potential cannabis impairment in drivers.
Wednesday February 24, 2021 3 - 4 PM
Dr. Joanne Bezzubetz President and CEO of The Royal
